Insmed Inc. buy Guggenheim
Start price
18.12.25
/
50%
€142.00
Target price
18.12.26
€188.27
Performance (%)
-12.68%
Price
06.03.26
€120.00
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -12.68%. This prediction currently runs until 18.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -4.000% | -4.000% |
| iShares Core DAX® | -3,52 % | -4,99 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % |
| iShares S&P 500 | -0,82 % | -0,04 % |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Guggenheim from $230.00 to $221.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat